EU Clinical Studies Lack Proper Design, Informed Consent – FDA Survey
This article was originally published in The Gray Sheet
Executive Summary
European data used to support 510(k) and PMA submissions to FDA often are marred by major flaws in protocol noncompliance and study management, according to agency-observed trends
You may also be interested in...
EU Regulators Propose Additional Data Requirements For Device Trials
The European Commission's Clinical Evaluation Task Force (CETF) expects the EC to publish guidance by year-end detailing when literature submissions alone are sufficient for device trials to comply with the EU Medical Device Directive
Mission Harmonization: QS Certification Should Align With Business Goals
The comment period on the final draft international standard for medical device quality management (ISO 13485) is being extended by a month with the hope that it will facilitate European adoption of the standard
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.